ArticleJournal of Crohn's & colitis2025

Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison.

Beatriz Gros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.